Uphaus, Timo <br/><br/>
Disease reactivation after switching from natalizumab to daclizumab.  [electronic resource] 

 -  Journal of neurology  Dec 2017 
 - 2491-2494 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Observational Study 
<br/><br/><label>ISSN: </label>1432-1459 
<br/><br/><label>Standard No.: </label>10.1007/s00415-017-8622-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-Inflammatory Agents--therapeutic use<br/>Antibodies, Monoclonal, Humanized--adverse effects<br/>Daclizumab<br/>Drug Substitution--adverse effects<br/>Humans<br/>Immunoglobulin G--adverse effects<br/>Immunologic Factors--therapeutic use<br/>Magnetic Resonance Imaging<br/>Male<br/>Methylprednisolone--therapeutic use<br/>Multiple Sclerosis, Relapsing-Remitting--chemically induced<br/>Natalizumab--therapeutic use